1 citations
,
January 2015 in “Annals of Dermatology” This case report describes a 52-year-old woman who developed retiform purpura after using cocaine likely adulterated with levamisole, highlighting the need for levamisole detection in such cases.
7 citations
,
July 2020 in “Journal of The American Academy of Dermatology” This article discusses the challenges of attributing skin manifestations to COVID-19, emphasizing the need for more studies to differentiate virus-specific lesions from nonspecific ones, and reports no new clinical results.
This study reports an increase in the frequency and variety of skin conditions associated with COVID-19, noting that milder cases often present with pernio-like lesions, while severe cases may involve livedo racemosa, retiform purpura, and acral ischemia.
May 2021 in “Bőrgyógyászati és venerológiai szemle” This review summarizes literature and experiences on the skin manifestations in COVID-19 patients, suggesting some may help identify asymptomatic cases, but it reports no new clinical results.
April 2025 in “JAAD reviews.” This review provides an overview of skin manifestations associated with substance use disorder but reports no new clinical findings; the authors emphasize the importance of dermatological evaluation and multidisciplinary care in managing these cases.